Search results for PX-TA1297

Showing 1 – 10 of1products
Lirilumab Biosimilar – Anti-KIRD2 subgroup mAb – Research Grade Brand Logo
ID: BAB743024081

Lirilumab Biosimilar – Anti-KIRD2 subgroup mAb – Research Grade, ProteoGenix, PX-TA1297

Description of Lirilumab Biosimilar - Anti-KIRD2 subgroup mAb - Research Grade General information on Anti-KIRD2 subgroup[Homo sapiens] (Lirilumab) Monoclonal Antibody Lirilumab has been investigated for the treatment of Leukemia, Cancer, Multiple Myeloma, Lymphocytic Leukemia, and Acute Myeloid Leukemia.

Host

Reactivity

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.